Home Authors Posts by Mary Kathleen Flynn

Mary Kathleen Flynn

Mary Kathleen (MK) Flynn joined PEI Media as Editor-in-Chief of PE Hub in 2021. She leads the content for the Hub and covers all things private equity-related, especially transactions, trends and dealmakers. She has covered private equity and M&A for 15 years. Most recently, she was the Editor-in-Chief of Mergers & Acquisitions, a role she served in for a decade. Previous positions include Senior Editor/Senior Video Producer, The Deal; broadcast Reporter at CNN and MSNBC; and Associate Editor at U.S. News & World Report and PC Magazine.
KKR’s Pete Stavros, EQT’s Suzanne Donohoe and Warburg Pincus’ Chip Kaye
Featured thought leaders at the March 2025 summit also include Thoma Bravo’s Orlando Bravo, Luminate Capital’s Hollie Haynes and TPG’s Jon Winkelried.
Early in her career, at Grey Mountain Partners, Lesniak was the only female investor. Now as managing director at Norwest, she's the most powerful woman at the firm.
Taking the opportunity to 'start from scratch,' Kanji launched Astira Capital last year, with the firm quickly closing a $675m debut fund.
Andrea Auerback sitting at a desk, trees in background
'Much like covid variants, 2023’s challenges will evolve and expand as we head into 2024, and some might even abate.'
Her dealmaking prowess is considerable. Since joining the firm in 2007, she has been a key player in many of the 43 platform investments and 22 exits completed by the Kayne Partners team.
In this first episode of our miniseries, Private Markets and the End of Cheap Money, we talk to dealmakers from Corsair, OEP, Vestar and more to hear how sponsors are coping with the higher price of 'L' in LBOs.
'Buyers don't have the time or resources to compete in a drawn-out auction process, instead finding themselves willing to pay a steeper multiple to ensure they will win the asset and take it off the table extremely quickly,' explains Robert Reifman, managing director, Lincoln International.
EQT sold Aldevron for $9.6bn just 22 months after buying the maker of mRNA vaccine components for $3.4bn.
buyouts
buyouts

Copyright PEI Media

Not for publication, email or dissemination